| 000 | 01758 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250517094047.0 | ||
| 264 | 0 | _c20180205 | |
| 008 | 201802s 0 0 eng d | ||
| 022 | _a1530-0374 | ||
| 024 | 7 |
_a10.1097/GME.0000000000000617 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPinkerton, JoAnn V | |
| 245 | 0 | 0 |
_aConjugated estrogens and bazedoxifene in minority populations: pooled analysis of four phase 3 trials. _h[electronic resource] |
| 260 |
_bMenopause (New York, N.Y.) _c06 2016 |
||
| 300 |
_a611-20 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aBlack or African American |
| 650 | 0 | 4 |
_aBone Density _xdrug effects |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 |
_aDyspareunia _xdrug therapy |
| 650 | 0 | 4 |
_aEstrogen Replacement Therapy _xmethods |
| 650 | 0 | 4 |
_aEstrogens, Conjugated (USP) _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHispanic or Latino |
| 650 | 0 | 4 |
_aHot Flashes _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aHydrogen-Ion Concentration |
| 650 | 0 | 4 |
_aIndoles _xadministration & dosage |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMinority Groups |
| 650 | 0 | 4 | _aPlacebos |
| 650 | 0 | 4 | _aPostmenopause |
| 650 | 0 | 4 | _aQuality of Life |
| 650 | 0 | 4 |
_aSelective Estrogen Receptor Modulators _xadministration & dosage |
| 650 | 0 | 4 |
_aVagina _xchemistry |
| 650 | 0 | 4 | _aWhite People |
| 700 | 1 | _aPickar, James H | |
| 700 | 1 | _aRyan, Kelly A | |
| 700 | 1 | _aYu, Ching-Ray | |
| 700 | 1 | _aMirkin, Sebastian | |
| 700 | 1 | _aKomm, Barry S | |
| 773 | 0 |
_tMenopause (New York, N.Y.) _gvol. 23 _gno. 6 _gp. 611-20 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/GME.0000000000000617 _zAvailable from publisher's website |
| 999 |
_c26005325 _d26005325 |
||